Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frances Balkwill

Showing results (11-20 of 58) with videos related to

Pageof 6
Sort By:
Nature Medicine|February 8, 2014
Chemotherapy, immunity and microbiota--a new triumvirate?Michael Karin, Christian Jobin, Frances Balkwill
Trends in Cancer|October 1, 2023
Interferon epsilon and ovarian cancerSamar Elorbany, Beatrice Malacrida, Frances Balkwill
Cancer Cell|October 16, 2007
Inflammation and cancer: a double-edged swordThorsten Hagemann, Frances Balkwill, Toby Lawrence
Cancer Cell|March 16, 2005
Smoldering and polarized inflammation in the initiation and promotion of malignant diseaseFrances Balkwill, Kellie A Charles, Alberto Mantovani
Nature|July 25, 2008
Cancer-related inflammationAlberto Mantovani, Paola Allavena, Antonio Sica, et al.
Scientific Reports|April 7, 2023
The impact of pericytes on the stability of microvascular networks in response to nanoparticlesMatthew Dibble, Stefania Di Cio', Piaopiao Luo, et al.
Iscience|April 24, 2023
Semi-supervised analysis of myeloid and T cell behavior in <i>ex vivo</i> ovarian tumor slices reveals changes in cell motility after treatmentsFlorian Laforêts, Panoraia Kotantaki, Beatrice Malacrida, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|April 13, 2004
A modified medium that significantly improves the growth of human normal ovarian surface epithelial (OSE) cells in vitroNingfeng F Li, George Wilbanks, Frances Balkwill, et al.
Journal of Leukocyte Biology|September 29, 2021
Loss of mTORC2-induced metabolic reprogramming in monocytes uncouples migration and maturation from production of proinflammatory mediatorsMaryam Jangani, Juho Vuononvirta, Lamya Yamani, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 8, 2010
Human T-lymphotropic virus type 1-induced CC chemokine ligand 22 maintains a high frequency of functional FoxP3+ regulatory T cellsFrederic Toulza, Kisato Nosaka, Yuetsu Tanaka, et al.
Pageof 6

Showing results (11-20 of 58) with videos related to

Sort By:
Pageof 6
Nature Medicine|February 8, 2014
Chemotherapy, immunity and microbiota--a new triumvirate?Michael Karin, Christian Jobin, Frances Balkwill
Trends in Cancer|October 1, 2023
Interferon epsilon and ovarian cancerSamar Elorbany, Beatrice Malacrida, Frances Balkwill
Cancer Cell|October 16, 2007
Inflammation and cancer: a double-edged swordThorsten Hagemann, Frances Balkwill, Toby Lawrence
Cancer Cell|March 16, 2005
Smoldering and polarized inflammation in the initiation and promotion of malignant diseaseFrances Balkwill, Kellie A Charles, Alberto Mantovani
Nature|July 25, 2008
Cancer-related inflammationAlberto Mantovani, Paola Allavena, Antonio Sica, et al.
Scientific Reports|April 7, 2023
The impact of pericytes on the stability of microvascular networks in response to nanoparticlesMatthew Dibble, Stefania Di Cio', Piaopiao Luo, et al.
Iscience|April 24, 2023
Semi-supervised analysis of myeloid and T cell behavior in <i>ex vivo</i> ovarian tumor slices reveals changes in cell motility after treatmentsFlorian Laforêts, Panoraia Kotantaki, Beatrice Malacrida, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|April 13, 2004
A modified medium that significantly improves the growth of human normal ovarian surface epithelial (OSE) cells in vitroNingfeng F Li, George Wilbanks, Frances Balkwill, et al.
Journal of Leukocyte Biology|September 29, 2021
Loss of mTORC2-induced metabolic reprogramming in monocytes uncouples migration and maturation from production of proinflammatory mediatorsMaryam Jangani, Juho Vuononvirta, Lamya Yamani, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 8, 2010
Human T-lymphotropic virus type 1-induced CC chemokine ligand 22 maintains a high frequency of functional FoxP3+ regulatory T cellsFrederic Toulza, Kisato Nosaka, Yuetsu Tanaka, et al.
Pageof 6